{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:58:30Z","timestamp":1793228310801,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bmcl.2022.128574","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T15:13:16Z","timestamp":1642605196000},"page":"128574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"60","author":[{"given":"Jing","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10181","key":"10.1016\/j.bmcl.2022.128574_b0005","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(19)30851-7","article-title":"Alzheimer\u2019s disease","volume":"393","author":"Barnett","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2022.128574_b0010","first-page":"1","article-title":"World Alzheimer Report 2018\u2014the state of the art of dementia research: new frontiers","author":"Patterson","year":"2018","journal-title":"Alzheimer\u2019s Disease International (ADI), London"},{"issue":"11","key":"10.1016\/j.bmcl.2022.128574_b0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"10.1016\/j.bmcl.2022.128574_b0020","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"5054","key":"10.1016\/j.bmcl.2022.128574_b0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"5580","key":"10.1016\/j.bmcl.2022.128574_b0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2022.128574_b0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.bmcl.2022.128574_b0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.bmcl.2022.128574_b0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer's disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.bmcl.2022.128574_b0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cobeha.2020.01.012","article-title":"Testing network properties of episodic memory using non-invasive brain stimulation","volume":"32","author":"Hebscher","year":"2020","journal-title":"Curr Opin Behav Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2022.128574_b0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1416","article-title":"The role of iron and reactive oxygen species in cell death","volume":"10","author":"Dixon","year":"2014","journal-title":"Nat Chem Biol"},{"issue":"7","key":"10.1016\/j.bmcl.2022.128574_b0060","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acs.accounts.9b00248","article-title":"Metal Ions in Alzheimer's Disease: A Key Role or Not?","volume":"52","author":"Liu","year":"2019","journal-title":"Acc Chem Res"},{"issue":"4","key":"10.1016\/j.bmcl.2022.128574_b0065","first-page":"184","article-title":"Cell biology of the neuron: Untangling the ubiquitin-proteasome system","volume":"19","author":"Lewis","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"10.1016\/j.bmcl.2022.128574_b0070","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd.2018.109","article-title":"Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing","volume":"17","author":"Boland","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.bmcl.2022.128574_b0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128574_b0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2019.05.020","article-title":"Multi-target design strategies for the improved treatment of Alzheimer's disease","volume":"176","author":"Zhang","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"29","key":"10.1016\/j.bmcl.2022.128574_b0085","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.2174\/0929867325666180111101843","article-title":"Multi-target directed drugs as a modern approach for drug design towards Alzheimer's disease: An update","volume":"25","author":"de Freitas","year":"2018","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2022.128574_b0090","unstructured":"http:\/\/integrity.thomson-pharma.com."},{"key":"10.1016\/j.bmcl.2022.128574_b0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejphar.2015.07.001","article-title":"Naringenin improves learning and memory in an Alzheimer's disease rat model: Insights into the underlying mechanisms","volume":"764","author":"Ghofrani","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2022.128574_b0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuroscience.2012.09.026","article-title":"Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats","volume":"226","author":"Rahigude","year":"2012","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bmcl.2022.128574_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ph12010011","article-title":"The therapeutic potential of naringenin: A review of clinical trials","volume":"12","author":"Salehi","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bmcl.2022.128574_b0110","doi-asserted-by":"crossref","unstructured":"Birks JS, Grimley Evans. Rivastigmine for Alzheimer\u2019s disease. Cochrane Database Syst Rev, 2015, (4): CH001191.","DOI":"10.1002\/14651858.CD001191.pub3"},{"key":"10.1016\/j.bmcl.2022.128574_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111958","article-title":"Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease","volume":"187","author":"Sang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128574_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112265","article-title":"Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"194","author":"Sang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128574_b0125","doi-asserted-by":"crossref","first-page":"621","DOI":"10.6023\/cjoc201210042","article-title":"Synthesis and biological evaluation of genistein carbamate derivatives","volume":"33","author":"Qiang","year":"2013","journal-title":"Chin J Org Chem"},{"key":"10.1016\/j.bmcl.2022.128574_b0130","article-title":"Therapeutic potential of multifunctional derivatives of cholinesterase inhibitors","author":"Przyby\u0142owska","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"17","key":"10.1016\/j.bmcl.2022.128574_b0135","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1016\/j.bmc.2009.07.046","article-title":"Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics","volume":"17","author":"Li","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2022.128574_b0140","article-title":"Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"128316","author":"Wu","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2022.128574_b0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2022.128574_b0150","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acschemneuro.8b00530","article-title":"Design, synthesis, and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"10","author":"Sang","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmcl.2022.128574_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112180","article-title":"The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"192","author":"Sang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128574_b0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2019.02.012","article-title":"Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitorsof cholinesterases, cyclooxygenase-2 and 15-lipoxygenase","volume":"167","author":"AlFadly","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2022.128574_b0165","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41467-018-03509-0","article-title":"A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers","volume":"9","author":"Thibaudeau","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2022.128574_b0170","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur J Med Chem"},{"issue":"Pt B","key":"10.1016\/j.bmcl.2022.128574_b0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbr.2016.08.027","article-title":"Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease","volume":"322","author":"Cortese","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bmcl.2022.128574_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104895","article-title":"Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents","volume":"111","author":"Ye","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2022.128574_b0185","unstructured":"http:\/\/www.molinspiration.com\/cgi-bin\/properties. Sept. 02, 2021."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22000506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22000506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:43:04Z","timestamp":1760773384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22000506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":37,"alternative-id":["S0960894X22000506"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128574","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128574"}}